Viatris (VTRS) news

Monkeypox stocks rose in regular trading, with TNXP up 6.8%, GILD gaining 2.5% and VTRS rising 1.9%.

On October 14, 2026, shares of companies associated with monkeypox treatments and vaccines rose in regular trading. Tonix Pharmaceuticals Holding Corp (TNXP) gained 6.8%, while Gilead Sciences (GILD) rose 2.5%, and Verrica Pharmaceuticals (VTRS) increased by 1.9%. The uptick in stock prices…

New Retail stocks rose in regular trading, with MNSO up 5.9%, BABA gaining 5.4% and VIOT rising 4.3%.

Retail stocks showed gains in regular trading on Tuesday, with several names posting notable increases. Among them, Mansana Corp (MNSO) rose 5.9%, while Alibaba Group (BABA) added 5.4%. Viatris Inc. (VIOT) also saw a 4.3% increase in share price. The moves reflect renewed investor interest in the…

Pacira Biosciences, Inc.: Jefferies cuts to hold from buy

Jefferies & Co. has downgraded its rating for Pacira BioSciences, Inc. (Nasdaq: PCRX) from "Buy" to "Hold," citing recent developments in the company's strategic direction and market dynamics. The move follows Pacira's announcement of its pending acquisition by Viatris Inc. (Nasdaq: VTRS), a global…

Viatris - Pacira to pay Viatris $62 mln termination fee under specified circumstances - SEC filing

Trading released/resumed: (PcRx) Reason not available

Trading in shares of Pacira BioSciences, Inc. (PCRX) was briefly impacted on October 8, 2026, following the release of an incorrect alert regarding share price movement, which was promptly withdrawn by Reuters . The alert had no bearing on the company’s operations or financial performance but may…